Table of Contents Table of Contents
Previous Page  118-119 / 956 Next Page
Information
Show Menu
Previous Page 118-119 / 956 Next Page
Page Background

Spinelli Coelho PL, et al. Safety of human papillomavirus 6, 11, 16 and 18

(recombinant): systematic review and meta-analysis.

Rev Paul Pediatr

.

2014;33(4).

http://www.scielo.br/scielo.php?script=sci_arttext&pid=S0103- 05822015000400017

Prescrire. Human papillomavirus vaccines: 2014 safety review.

Prescrire Int

.

2015;24(160):122-9.

http://english.prescrire.org/en/81/168/49937/0/NewsDetails.aspx?page=6

Global Advisory Committee on Vaccine Safety, 2–3 December 2015.

Weekly

Epidemiol Rec

. 2016;91(3):21-32.

http://www.who.int/wer/2016/wer9103.pdf?ua=1

ANSM

. Vaccination contre les infections à HPV et risque de maladies auto-

immunes: une étude Cnamts/ANSM rassurante - Point d'information,

13/sep/2015.

http://ansm.sante.fr/S-informer/Points-d-information-Points-d- information/Vaccination-contre-les-infections-a-HPV-et-risque-de-maladies- auto-immunes-une-etude-Cnamts-ANSM-rassurante-Point-d-information

Forinash AB. Safety of the HPV Bivalent and Quadrivalent Vaccines During

Pregnancy.

Ann Pharmacother

. 2011;45(2):258-62.

http://www.ncbi.nlm.nih.gov/pubmed/21285408

Narducci A, et al. Human papillomavirus vaccine and pregnancy.

Can Fam

Physician

. 2012;58(3):268-9.

http://www.ncbi.nlm.nih.gov/pmc/articles/PMC3303646/